Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Julphar
Citi
Baxter
Federal Trade Commission
Fuji
Dow
Express Scripts

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065502

« Back to Dashboard

NDA 065502 describes RIFAMPIN, which is a drug marketed by Akorn, Lannett Co Inc, Lupin Pharms, Sandoz, Emcure Pharms Ltd, Fresenius Kabi Usa, Hikma Pharms, Mylan Labs Ltd, Watson Pharms Teva, West-ward Pharms Int, and Hikma Intl Pharms, and is included in twelve NDAs. It is available from twenty-four suppliers. Additional details are available on the RIFAMPIN profile page.

The generic ingredient in RIFAMPIN is isoniazid; rifampin. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the isoniazid; rifampin profile page.
Summary for 065502
Tradename:RIFAMPIN
Applicant:Akorn
Ingredient:rifampin
Patents:0
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 065502
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIFAMPIN rifampin INJECTABLE;INJECTION 065502 ANDA AKORN, Inc. 17478-151 N 17478-151-42

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength600MG/VIAL
Approval Date:Sep 21, 2010TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fuji
Julphar
Harvard Business School
Cantor Fitzgerald
Dow
Express Scripts
Johnson and Johnson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.